Dr. Lalchandani Labs Ltd.
BSE: DLCL
Prev Close
22.04
Open Price
22.49
Volume
76,000
Today Low / High
20.94 / 23
52 WK Low / High
9.8 / 23
Range
21 - 23
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 22.24, reflecting a change of 0.2 (0.90744%). The expected target range on the BSE is 21 - 23. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Dr. Lalchandani Labs Ltd. Graph
Dr. Lalchandani Labs Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Dr. Lalchandani Labs Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 22.24, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 22.24 | 22.46 | 20.22 - 24.71 |
| 22.68 | 18.15 - 27.22 | ||
| 22.91 | 16.04 - 29.78 | ||
| Bearish Scenario | 22.24 | 22.02 | 19.82 - 24.22 |
| 21.80 | 17.44 - 26.15 | ||
| 21.57 | 15.10 - 28.04 |
Overview of Dr. Lalchandani Labs Ltd.
ISIN
INE871Z01013
Industry
Medical - Care Facilities
Vol.Avg
37,405
Market Cap
96,367,477
Last Dividend
0
Official Website
IPO Date
2024-12-30
DCF Diff
28.13
DCF
-6
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.45 Cr | 0.96 Cr | 3.50 Cr | 0.7853 | 0.00 Cr | 0.00 Cr | 0.36 Cr | 0.42 Cr | 0.96 | 1.05 Cr | 0.0937 |
| 2024-03-31 | 4.81 Cr | 3.13 Cr | 1.68 Cr | 0.3489 | 0.00 Cr | 0.58 Cr | 1.07 Cr | 0.62 Cr | 1.43 | 0.23 Cr | 0.1284 |
| 2023-03-31 | 5.04 Cr | 1.21 Cr | 3.83 Cr | 0.7590 | 0.00 Cr | 0.25 Cr | -0.44 Cr | -1.56 Cr | -3.61 | -0.02 Cr | -0.3101 |
| 2022-03-31 | 11.28 Cr | 2.98 Cr | 8.30 Cr | 0.7362 | 0.00 Cr | 0.71 Cr | 1.90 Cr | 0.93 Cr | 2.15 | 2.42 Cr | 0.0827 |
| 2021-03-31 | 9.78 Cr | 3.61 Cr | 6.17 Cr | 0.6310 | 0.00 Cr | 0.49 Cr | 1.74 Cr | 1.01 Cr | 2.33 | 2.10 Cr | 0.1034 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.30 Cr | 15.75 Cr | 5.79 Cr | 9.9571 Cr | 4.07 Cr | 0.77 Cr | 1.29 Cr | 3.26 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 5.6628 Cr |
| 2024-03-31 | 2.29 Cr | 14.99 Cr | 5.45 Cr | 9.5399 Cr | 3.48 Cr | 1.19 Cr | 1.44 Cr | 3.70 Cr | 0.00 Cr | 0.00 Cr | 0.41 Cr | 5.0301 Cr |
| 2023-03-31 | 3.10 Cr | 17.72 Cr | 8.80 Cr | 8.9225 Cr | 6.40 Cr | 3.30 Cr | 1.52 Cr | 5.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 5.3201 Cr |
| 2022-03-31 | 3.53 Cr | 18.12 Cr | 7.64 Cr | 10.4853 Cr | 5.14 Cr | 1.61 Cr | 1.56 Cr | 5.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 4.8611 Cr |
| 2021-03-31 | 2.89 Cr | 15.20 Cr | 5.64 Cr | 9.5520 Cr | 4.04 Cr | 1.15 Cr | 0.68 Cr | 4.74 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 2.8696 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.4430 Cr | 0.0587 Cr | 0.5032 Cr | 0.2883 Cr | 1.0049 Cr | 3.2973 Cr | -0.1547 Cr | 0.4022 Cr | 0.5886 Cr | 0.0000 Cr | 0.1408 Cr |
| 2024-03-31 | -0.2180 Cr | 0.9965 Cr | -1.5886 Cr | -0.3330 Cr | -0.8100 Cr | 2.2924 Cr | -0.1150 Cr | 0.6175 Cr | -3.0545 Cr | 0.0000 Cr | 0.0873 Cr |
| 2023-03-31 | 0.0013 Cr | -0.1966 Cr | -0.2349 Cr | -0.3035 Cr | -0.4303 Cr | 3.1024 Cr | -0.3048 Cr | -1.5628 Cr | 0.6418 Cr | 0.0000 Cr | 0.0337 Cr |
| 2022-03-31 | 2.0056 Cr | -1.5291 Cr | 0.1638 Cr | 0.9102 Cr | 0.6403 Cr | 3.5327 Cr | -1.0954 Cr | 1.2869 Cr | 0.6456 Cr | 0.0000 Cr | -0.8791 Cr |
| 2021-03-31 | 1.1880 Cr | -2.2587 Cr | 1.7104 Cr | -1.0997 Cr | 0.6396 Cr | 2.8924 Cr | -2.2877 Cr | 1.3774 Cr | 1.8897 Cr | 0.0000 Cr | -0.1799 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.16 Cr | 0.50 Cr | 0.66 Cr | 0.5695 | 0.66 Cr | 0.13 Cr | 0.30 | 0.19 Cr | 0.1140 |
| 2024-12-31 | 1.16 Cr | 0.50 Cr | 0.66 Cr | 0.5695 | 0.66 Cr | 0.13 Cr | 0.30 | 0.19 Cr | 0.1140 |
| 2024-09-30 | 1.06 Cr | 0.39 Cr | 0.67 Cr | 0.6325 | 0.67 Cr | 0.08 Cr | 0.18 | 0.27 Cr | 0.0715 |
| 2024-06-30 | 1.06 Cr | 0.39 Cr | 0.67 Cr | 0.6325 | 0.67 Cr | 0.08 Cr | 0.18 | 0.27 Cr | 0.0715 |
| 2024-03-31 | 1.04 Cr | 0.64 Cr | 0.40 Cr | 0.3822 | 0.09 Cr | 0.35 Cr | 0.83 | -0.06 Cr | 0.3387 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.30 Cr | 0.00 Cr | 3.30 Cr | 5.26 Cr | 1.29 Cr | 10.87 Cr | 3.26 Cr | 15.75 Cr | 5.79 Cr |
| 2024-12-31 | 3.30 Cr | 0.00 Cr | 3.30 Cr | 5.26 Cr | 1.29 Cr | 10.87 Cr | 3.26 Cr | 15.75 Cr | 5.79 Cr |
| 2024-09-30 | 2.82 Cr | 0.00 Cr | 2.82 Cr | 4.87 Cr | 1.42 Cr | 10.22 Cr | 3.52 Cr | 15.37 Cr | 5.68 Cr |
| 2024-06-30 | 2.82 Cr | 0.00 Cr | 2.82 Cr | 4.87 Cr | 1.42 Cr | 10.22 Cr | 3.52 Cr | 15.37 Cr | 5.68 Cr |
| 2024-03-31 | 2.29 Cr | 0.00 Cr | 2.29 Cr | 4.70 Cr | 1.44 Cr | 9.48 Cr | 3.70 Cr | 14.99 Cr | 5.45 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.13 Cr | 0.03 Cr | 0.01 Cr | 0.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.03 Cr |
| 2024-12-31 | 0.13 Cr | 0.03 Cr | 0.01 Cr | 0.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.03 Cr |
| 2024-09-30 | 0.08 Cr | 0.19 Cr | 0.02 Cr | 0.05 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.08 Cr | 0.11 Cr |
| 2024-06-30 | 0.08 Cr | 0.19 Cr | 0.02 Cr | 0.05 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.08 Cr | 0.11 Cr |
| 2024-03-31 | 0.35 Cr | 1.24 Cr | 0.25 Cr | -1.55 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.06 Cr | 1.18 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,234.70 | ₹1,200,371,493,910.00 | ₹1,487,935.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,922.50 | ₹1,139,136,662,500.00 | ₹843,635.00 |
| Fortis Healthcare Limited | FORTIS | ₹934.40 | ₹705,432,755,200.00 | ₹1,777,868.00 |
| Global Health Limited | MEDANTA | ₹1,384.70 | ₹372,041,749,880.00 | ₹243,552.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,813.70 | ₹370,649,545,700.00 | ₹137,642.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹602.50 | ₹312,167,902,500.00 | ₹919,644.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹736.80 | ₹294,822,415,200.00 | ₹188,342.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,577.40 | ₹160,187,610,568.00 | ₹38,800.00 |
| HealthCare Global Enterprises Limited | HCG | ₹677.70 | ₹94,481,545,500.00 | ₹76,902.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹716.15 | ₹69,004,171,333.00 | ₹283,413.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹459.50 | ₹42,123,743,500.00 | ₹140,362.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹238.02 | ₹33,060,978,000.00 | ₹68,033.00 |
Key Executives
Gender: male
Year Born: 1986
Gender: female
Year Born: 1986
Gender: female
Year Born:
Gender: Not Specified
Year Born: 1952
FAQs about Dr. Lalchandani Labs Ltd.
The CEO is Mohit Lalchandani.
The current price is ₹22.24.
The range is ₹9.8-23.
The market capitalization is ₹9.64 crores.
The P/E ratio is 23.19.
The company operates in the Healthcare sector.
Overview of Dr. Lalchandani Labs Ltd. (ISIN: INE871Z01013) is a leading Medical - Care Facilities in India. With a market capitalization of ₹9.64 crores and an average daily volume of 37,405 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.